Tissue-Type Plasminogen Activator in Patients with Intracranial Meningiomas

Summary

Three of 13 patients with intracranial meningiomas showed the pre- and postoperative elevation of tissue-type plasminogen activator (t-PA) related fibrinolytic activity in euglobulin fractions (EFA). During operation, two of these three patients showed a significant elevation of the level of fibrin(ogen) degradation products and oozing in the operating field. However, oozing was not observed in the third patient who had been given tranexamic acid preoperatively. Fibrin autography revealed that a broad lytic band of mol wt 50–60 kDa, probably free t-PA, appeared in the plasma obtained from two of the three patients after operation when EFA elevated significantly. In all patients studied, the t-PA antigen levels were normal preoperatively but increased both during and after operation, and correlated mainly with the intensities of a lytic band of mol wt 110 kDa, probably t-PA complexed with its major inhibitor (PAI–1). These results suggest that the excessive fibrinolysis can induce the local hemorrhagic diathesis during operation and may be related to t-PA function in plasma

Keywords

Intracranial meningiomas - Euglobulin fibrinolytic activity - Tissue-type plasminogen activator

• References

• 1 White WF, Barlow GH, Mozen MM. The isolation and characterization of plasminogen activator (urokinase) from human urine. Biochemistry 1966; 5: 2160-2169
• 2 Rijken DC, Wijngaards G, Zaal-de-Jong M, Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 1979; 580: 140-153
• 3 Wun T-C, Schleuning W-D, Reich E. Isolation and characterization of urokinase from human plasma. J Biol Chem 1982; 257: 3276-3283
• 4 Rijken DC, Wijngaards G, Welbergen J. Relationship between uterine tissue plasminogen activater and the activaters in blood and vascular wall. Thromb Res 1980; 18: 815-830
• 5 Prowse CV, Cash JD, Path MR C. Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Hemostas 1984; 10: 51-60
• 6 Northfield DW C. The Surgery of the Central Nervous System. Blackwell Scientific Publications; Oxford: 1973
• 7 Takashima S, Koga M, Tanaka M. Fibrinolytic activity of human brain and cerebrospinal fluid. Br J Exp Pathol 1969; 50: 533-539
• 8 Koos W, Valencak E, Kraus H, Blumel G, Bock F. L’activité fibrinolytique relevée dans les tumeurs intra-craniennes. Neuro-Chirurgie 1971; 17: 549-558
• 9 Tucker WS, Kirsch WM, Martinez-Hemandez A, Fink LM. In vitro plasminogen activator activity in human brain tumors. Cancer Res 1978; 38: 297-302
• 10 Oka K, Tsuda H, Kamikaseda K, Nakamura R, Fukui M, Noutsuka Y, Sueishi K. Meningiomas and hemorrhagic diathesis. J Neurosurgery (in press)
• 11 Granelli-Piperno A, Reich E. A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 1978; 148: 223-234
• 12 von Kaulla KN, Schultz RL. Methods for the evaluation of human fibrinolysis. Studies with two combined technics. Am J Clin Pathol 1958 29. 104-109
• 13 Bergsdorf N, Nilsson T, Wallén P. An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb Haemostas 1983; 50: 740-744
• 14 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-240
• 15 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 16 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041
• 17 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 18 Lundbald RL, Kingdon HS, Mann KG. Thrombin. In: Methods in Enzymology Lorand L. (ed) Vol 45 Academic Press; New York: 1976. pp 156-176
• 19 Tissot J-D, Schneider P, Hauert J, Ruegg M, Kruithof EK O, Bachmann F. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase. J Clin Invest 1982; 70: 1320-1323
• 20 Kruithof EK O, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913
• 21 Stalder M, Hauert J, Kruithof EK O, Bachmann F. Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA. Br J Haematol 1985; 61: 169-176
• 22 Booth NA, Walker E, Maughan R, Bennett B. Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1. Blood 1987; 69: 1600-1604
• 23 Booth NA, Anderson JA, Bennett B. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. J Clin Pathol 1984; 37: 772-777
• 24 Muramatu M, Fujii S. Inhibitory effects of ω-guanidino acid esters on trypsin, plasmin, thrombin and plasma kallikrein. J Biochem 1968; 64: 807-814
• 25 Kwaan HC. The role of fibrinolysis in desease processes. Semin Thromb Hemostas 1984; 10: 71-79
• 26 Wun T-C, Capuano A. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. Blood 1987; 69: 1354-1362
• 27 Rijken DC, van Hinsberg VW M, Sens EH C. Quantitation of tissue-type plasminogen activator in human endotherial cell cultures by use of an enzyme immunoassay. Thromb Res 1984; 33: 145-153
• 28 Kluft C, Verheijen JH, Jie AF H, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45: 605-610
• 29 Mellbring G, Nilsson T, Bergsdorf N, Wallén P. Tissue plasminogen activator concentrations in major abdominal surgery. Relationship to postoperative deep vein thrombosis. Thromb Res 1984 36. 331-334
• 30 Páramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor - Relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemostas 1985; 54: 713-716